Middle East and Africa Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)
Market Introduction
The Middle East & Africa Leukapheresis market is analyzed based on three large countries: Saudi Arabia, the UAE, South Africa, and Rest of MEA. Saudi Atabia is contributing a major share in the growth of leukapheresis market. Saudi Arabia is one of the fastest-growing regions in the Middle East & Africa, which is being driven by a huge population base and increasing acceptance of medical devices. To achieve Vision 2030, the government of Saudi Arabia launched a National Transformation Program in 2016. The government had launched this program for the overall development of Saudi Arabia across all industries. In addition, this program is linked to the implementation of primary and digital infrastructure projects in several industries. Under this program, the government focuses on consolidating and transforming the health system by increasing the accessibility of health services, improving health efficiency and quality, and preventing chronic diseases. This government-approved strategic policy creates lucrative medical device launch opportunities that will ultimately fuel the Leukapheresis market growth in Saudi Arabia over the forecast period. Increased awareness of health issues and increased consumption of health services contribute to a significant market for medical devices.
Middle East & Africa have been witnessing a growing number of COVID-19 cases since its outbreak. Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in deep economic recession due to the US sanctions. Also, the major source of economic stabilization in Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East region. Further, the adoption of plasma therapy for covid patients is impacting the market in the positive way. UAE is turning to a century-old treatment for viral disease that is showing promise with patients. Known as Convalescent Plasma therapy, it involves taking virus-killing antibodies from the blood of people who have recovered from the disease and donating them to the critically ill. With anti-virals still undergoing human trials and a vaccine at least a year away, CP therapy is being seen as a vital stopgap measure against the pandemic in the region. On April 12, 2020, medics at Sheikh Khalifa Medical City in Abu Dhabi announced that they were treating a patient with the plasma of an Emirati who had recovered from the virus.
Get more information on this report :
Market Overview and Dynamics
The leukapheresis market in Middle East & Africa is expected to grow from US$ 3.77 million in 2021 to US$ 6.20 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2021 to 2028. Blood diseases disturb the overall well-being of patients. Anemia; hemophilia; von Willebrand disease (VWD); blood cancers such as myeloma, leukemia, and lymphoma are among the common blood diseases. The number of newly diagnosed leukemia cases increased from 354,500 in 1990 to 518,500 in 2017. Further, according to the National Heart, Lung, and Blood Institute, anemia affects more than 3 million Americans every year, while as per the WHO, it affects ~1.62 billion people worldwide. According to the Centers of Disease Control and Prevention (CDC), hemophilia A affects ~1 in 5,000 male births. The CDC survey for 2017 reported that Von Willebrand disease (VWD), one of the most commonly occurring bleeding disorders, affects up to 1% of the population. More than 14,600 men, women, and children were seen at hemophilia treatment centers for the treatment of VWD during 2012–2016. The rising incidence of these diseases maximizes the need for blood transfusion, thereby bolstering the demand for leukapheresis equipment. Two of the most common types of apheresis used for the removal of harmful substances from blood are cytapheresis and plasma exchange. Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, and multiple sclerosis. Cytapheresis, a process that removes the excess number of blood cells, is used in the treatment of leukemia, polycythemia, and thrombocythemia, among others.
Key Market Segments
In terms of product type, the leukapheresis disposables segment held a larger share in 2021. Based on application, research applications segment held the largest share in 2021. Based on end user, blood component providers and blood centers segment held the largest share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the leukapheresis market in Middle East & Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Haemonetics Corporation; Terumo Corporation; STEMCELL Technologies Inc.; HemaCare; Macopharma; AllCells; and BioIVT among others.
Reasons to buy report
- To understand the Middle East & Africa leukapheresis market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East & Africa leukapheresis market
- Efficiently plan M&A and partnership deals in Middle East & Africa leukapheresis market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East & Africa leukapheresis market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Middle East & Africa region.
Middle East & Africa Leukapheresis Market Segmentation
Middle East & Africa Leukapheresis Market – By Product Type
- Leukapheresis Disposables
- Leukapheresis Devices
Middle East & Africa Leukapheresis Market – By Application
- Research Applications
- Therapeutic Applications
Middle East & Africa Leukapheresis Market – By Product Type
- Blood Component Providers and Blood Centers
- Hospitals and Transfusion Centers
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
Middle East & Africa Leukapheresis Market – By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Middle East & Africa Leukapheresis Market – Companies Mentioned
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Leukapheresis Market – By Product Type
1.3.2 Middle East & Africa Leukapheresis Market – By Application
1.3.3 Middle East & Africa Leukapheresis Market – By End User
1.3.4 Middle East & Africa Leukapheresis Market – By Country
2. Middle East & Africa Leukapheresis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Leukapheresis – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. Middle East & Africa Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Scaling Number of Voluntary Blood Donors
5.1.2 Surging Incidence of Hematologic Diseases
5.1.3 Increasing Elderly Population
5.2 Key Market Restraints
5.2.1 High Cost of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Elevating Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Evolution in Therapeutic Apheresis
5.5 Impact Analysis
6. Middle East & Africa Leukapheresis – Market Analysis
6.1 Middle East & Africa Leukapheresis Market Revenue Forecast and Analysis
7. Middle East & Africa Leukapheresis Market Analysis – by Product Type
7.1 Overview
7.2 Middle East & Africa Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Leukapheresis ColuMillions and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Leukapheresis Market Analysis – by Application
8.1 Overview
8.2 Middle East & Africa Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Leukapheresis Market Analysis – by End User
9.1 Overview
9.2 Middle East & Africa Leukapheresis Market Share by End-User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Leukapheresis Market – Country Analysis
10.1 Overview
10.1.1 Middle East & Africa: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.1.1.1 Saudi Arabia: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 Saudi Arabia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 Saudi Arabia Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3.1 Saudi Arabia: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.1.4 Saudi Arabia: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.1.5 Saudi Arabia Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.2 UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Overview
10.1.1.2.2 UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3 UAE Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3.1 UAE: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.2.4 UAE: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.2.5 UAE Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.3 South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 South Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3.1 South Africa: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.3.4 South Africa: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.3.5 South Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.4 Rest of Middle East & Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3 Rest of Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3.1 Rest of Middle East & Africa: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.4.4 Rest of Middle East & Africa: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.4.5 Rest of Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Middle East & Africa Leukapheresis Market – Impact of COVID-19 Pandemic
11.1 Impact Assessment of COVID-19 Pandemic
12. Middle East & Africa Leukapheresis Market – Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 BioIVT
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. UAE Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of Middle East & Africa Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of Middle East & Africa Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, Leukapheresis Market
LIST OF FIGURES
Figure 1. Middle East & Africa Leukapheresis Market Segmentation
Figure 2. Middle East & Africa Leukapheresis Market Segmentation, By country
Figure 3. Middle East & Africa Leukapheresis Market Overview
Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market
Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period
Figure 6. Middle East & Africa Leukapheresis Market, Industry Landscape
Figure 7. Middle East & Africa PEST Analysis
Figure 8. Middle East & Africa Leukapheresis market impact analysis of driver and restraints
Figure 9. Middle East & Africa Leukapheresis Market – Revenue Forecast and Analysis to 2020-2028
Figure 10. Middle East & Africa Leukapheresis Market Share by Product Type 2021 & 2028 (%)
Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Middle East & Africa Leukapheresis Market Share by Application 2021 & 2028 (%)
Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Middle East & Africa Leukapheresis Market Share by End-User 2021 & 2028 (%)
Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Middle East & Africa: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 25. Middle East & Africa: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 26. Saudi Arabia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Rest of Middle East & Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. Impact Of COVID-19 Pandemic In Middle East & Africa Market
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- BioIVT
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa leukapheresis market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution